Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raoul Tibes

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|May 24, 2011
Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?Raoul Tibes, Ruben A Mesa
Journal of Hematology & Oncology|March 7, 2014
Targeting hedgehog signaling in myelofibrosis and other hematologic malignanciesRaoul Tibes, Ruben A Mesa
Frontiers in Oncology|January 11, 2020
Transcriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid LeukemiaRaoul Tibes, James M Bogenberger
Expert Opinion on Emerging Drugs|August 24, 2013
Emerging drugs for polycythemia veraRaoul Tibes, Ruben A Mesa
Leukemia Research|March 31, 2012
Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniquesRaoul Tibes, Ruben A Mesa
Annual Review of Pharmacology and Toxicology|April 12, 2005
Tyrosine kinase inhibitors and the dawn of molecular cancer therapeuticsRaoul Tibes, Jonathan Trent, Razelle Kurzrock
Targeted Oncology|April 23, 2020
Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and BeyondJun H Choi, James M Bogenberger, Raoul Tibes
Current Hematologic Malignancy Reports|December 16, 2011
Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?Madappa N Kundranda, Raoul Tibes, Ruben A Mesa
Hematology (Amsterdam, Netherlands)|April 18, 2012
JAK2 inhibitors and their impact in myeloproliferative neoplasmsHolly L Geyer, Raoul Tibes, Ruben A Mesa
Expert Opinion on Investigational Drugs|September 21, 2012
JAK2 inhibitors in the treatment of myeloproliferative neoplasmsRaoul Tibes, James M Bogenberger, Holly L Geyer, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|May 24, 2011
Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?Raoul Tibes, Ruben A Mesa
Journal of Hematology & Oncology|March 7, 2014
Targeting hedgehog signaling in myelofibrosis and other hematologic malignanciesRaoul Tibes, Ruben A Mesa
Frontiers in Oncology|January 11, 2020
Transcriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid LeukemiaRaoul Tibes, James M Bogenberger
Expert Opinion on Emerging Drugs|August 24, 2013
Emerging drugs for polycythemia veraRaoul Tibes, Ruben A Mesa
Leukemia Research|March 31, 2012
Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniquesRaoul Tibes, Ruben A Mesa
Annual Review of Pharmacology and Toxicology|April 12, 2005
Tyrosine kinase inhibitors and the dawn of molecular cancer therapeuticsRaoul Tibes, Jonathan Trent, Razelle Kurzrock
Targeted Oncology|April 23, 2020
Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and BeyondJun H Choi, James M Bogenberger, Raoul Tibes
Current Hematologic Malignancy Reports|December 16, 2011
Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?Madappa N Kundranda, Raoul Tibes, Ruben A Mesa
Hematology (Amsterdam, Netherlands)|April 18, 2012
JAK2 inhibitors and their impact in myeloproliferative neoplasmsHolly L Geyer, Raoul Tibes, Ruben A Mesa
Expert Opinion on Investigational Drugs|September 21, 2012
JAK2 inhibitors in the treatment of myeloproliferative neoplasmsRaoul Tibes, James M Bogenberger, Holly L Geyer, et al.
Pageof 8